Evaluation of platelet aggregation in the presence of antiphospholipid antibodies: anti-β2GP1 and anticardiolipin

被引：6
|
作者：
de Mesquita, Harleson Lopes [1 ]
de Carvalho, Giuliano Reder [1 ]
Aarestrup, Fernando Monteiro [2 ]
do Amaral Correa, Jose Otavio [3 ]
Andrade Azevedo, Maria Regina [4 ]
机构：
[1] Univ Santo Amaro, Dept Clin Anal, Sao Paulo, Brazil
[2] Univ Fed Juiz de Fora, Ctr Reprod Biol, Juiz De Fora, MG, Brazil
[3] Univ Fed Juiz de Fora, Fac Pharmacol, Juiz De Fora, MG, Brazil
[4] Univ Sao Paulo, Dept Clin Anal, Sao Paulo, Brazil
来源：
REVISTA BRASILEIRA DE REUMATOLOGIA | 2013年 / 53卷 / 05期
关键词：
Antiphospholipid syndrome; Antiphospholipid antibodies; Platelet agreggation; UPDATE; BETA(2)-GLYCOPROTEIN-I; DIAGNOSIS;
D O I：
10.1590/S0482-50042013000500006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Introduction: The antiphospholipid syndrome (APS) is an autoimmune condition characterized by recurrent arterial and venous thrombosis, besides obstetric complications. The pathogenesis is associated with the presence of antiphospholipid and/or anti-b2-glicoprotein I (anti-b2GPI) antibodies that appear to change the anticoagulant activity of b2GPI. Antibody-induced dimerization of b2GPI seems to be related to the induction of platelet aggregation, contributing to the development of thrombosis in APS. Objectives: The objective of the present study is to demonstrate the influence of antiphospholipid antibodies in platelet aggregation tests with different agonists (ADP, collagen, and adrenaline). Methods: We analyzed platelet aggregation tests with different agonists (ADP collagen, adrenalin) when normal platelets were exposed to serum with different concentrations of antiphospholipid antibodies. Results: Results demonstrated a significant inhibition in adrenalin- and ADP-induced platelet aggregation curves (P < 0.05) in all antibody concentrations tested when compared to the control. The paradox between the prothrombotic state and the presence of autoantibodies that show anticoagulant activity in vitro was demonstrated in the literature, making it difficult to understand the pathophysiologic mechanism of the antiphospholipid syndrome. Conclusion: Results showed that anticardiolipin and anti-b2GPI antibodies-rich serum, both of which belonging to the IgG class, can interfere with platelet aggregation curves. (C) 2013 Elsevier Editora Ltda. All rights reserved.
引用
收藏
页码：400 / 404
页数：5
相关论文
共 50 条
  • [41] The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome
    Chayoua, Walid
    Kelchtermans, Hilde
    Gris, Jean-Christophe
    Moore, Gary W.
    Musial, Jacek
    Wahl, Denis
    de Groot, Philip G.
    de Laat, Bas
    Devreese, Katrien M. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (01) : 169 - 179
  • [42] Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β2 glycoprotein I domain 1 antibodies
    Elbagir, S.
    Mohammed, N. A.
    Kaihola, H.
    Svenungsson, E.
    Gunnarsson, I
    Manivel, V. A.
    Pertsinidou, E.
    Elagib, E. M.
    Nur, M. A. M.
    Elussein, E. A.
    Elshafie, A.
    Akerud, H.
    Ronnelid, J.
    LUPUS, 2020, 29 (05) : 463 - 473
  • [43] The Clinical Performance of a New Chemiluminescent Immunoassay in Measuring Anti-β2 Glycoprotein 1 and Anti-Cardiolipin Antibodies
    Zhou, Jiansuo
    Hou, Xiuzhu
    Zhang, Hua
    Wang, Tiancheng
    Cui, Liyan
    MEDICAL SCIENCE MONITOR, 2018, 24 : 6816 - 6822
  • [44] Anti-coagulation effect of Fc fragment against anti-β2-GP1 antibodies in mouse models with APS
    Xie, Weidong
    Zhang, Yaou
    Bu, Cunya
    Sun, Shijing
    Hu, Shaoliang
    Cai, Guoping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (01) : 136 - 140
  • [45] Distinguishing features of anti-β2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome
    Arvieux, J
    Renaudineau, Y
    Mane, I
    Perraut, R
    Krilis, SA
    Youinou, P
    THROMBOSIS AND HAEMOSTASIS, 2002, 87 (04) : 599 - 605
  • [46] Anticardiolipin and anti-β2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits
    Avcin, T
    Ambrozic, A
    Kuhar, M
    Kveder, T
    Rozman, B
    RHEUMATOLOGY, 2001, 40 (05) : 565 - 573
  • [47] Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome
    Iwaniec, Teresa
    Kaczor, Marcin P.
    Celinska-Lowenhoff, Magdalena
    Polanski, Stanislaw
    Musial, Jacek
    THROMBOSIS RESEARCH, 2017, 153 : 90 - 94
  • [48] Estimation of anticardiolipin antibodies, anti-β2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis
    Avcin, T
    Ambrozic, A
    Bozic, B
    Accetto, A
    Kveder, T
    Rozman, B
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (01) : 101 - 108
  • [49] Isolated elevation of IgA anti-β2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients
    Kumar, S.
    Papalardo, E.
    Sunkureddi, P.
    Najam, S.
    Gonzalez, E. B.
    Pierangeli, S. S.
    LUPUS, 2009, 18 (11) : 1011 - 1014
  • [50] Binding of complement component C1q to anti-β2 glycoprotein I antibodies from patients with antiphospholipid syndrome
    Odorczuk, M
    Keil, LB
    DeBari, VA
    INFLAMMATION RESEARCH, 1999, 48 (10) : 524 - 526
12345